Integrated approach to IMRT provides quality care for head and neck cancer patientsOctober 29, 2007Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) for head and neck cancer can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process. The findings were presented today at the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles. "Our study demonstrates that it is feasible for head and neck cancer patients to receive IMRT in their own communities without sacrificing high-quality care," said Dwight Heron, M.D., associate professor of radiation oncology, University of Pittsburgh School of Medicine and director of radiation oncology, University of Pittsburgh Medical Center (UPMC). "This is possible through an integrated network in which treatment is standardized across all cancer centers." According to study results, there were no significant differences in toxicity profiles and treatment outcomes in 604 head and neck cancer patients treated with IMRT at 12 community cancer centers and one academic flagship facility. Two hundred and forty-eight patients (41 percent) were treated at the flagship facility, and 356 patients (59 percent) received IMRT at one of the community centers. All 13 centers, connected through a telemedicine network, followed the same clinical pathway guidelines for the radiotherapy management of head and neck cancer, which included specific details on volumes for radiation treatment planning and recommended doses of IMRT. When the investigators compared outcomes between the academic center and the community centers, they found that there were no significant differences between survival or recurrence rates.
"By standardizing planning and treatment for IMRT, patients who live in remote locations can benefit from the same quality of care available at a large National Cancer Institute-designated comprehensive cancer center," said Dr. Heron. "Bringing advanced radiation therapy to community locations can have a very positive effect on a patient's quality of life by relieving the anxiety and stress of traveling for treatment." University of Pittsburgh Schools of the Health Sciences Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Titanium Heparin Large Hadron Collider Proteins Hepatocellular Carcinoma Antiretroviral Ice Sheet Emissions MRSA Smoking Chocolate Ubiquitin Insecticide Children Childhood Cancer Leukemia Probiotic Pulmonary Embolism Puberty Tonsillectomy Threatened Species Pulsar Chest Pain Archaea Wine
See More: Science News Tags | |||||||||||||||||||||
|
Related Neck Cancer Current Events and Neck Cancer News Articles Oxygen + MRI might help determine cancer therapy success A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center. New treatment combination proves safe for head and neck cancer patients Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy. Experimental drug shows promise against head and neck cancer A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the April 28th online edition of the Journal of Pathology. Survey shows Americans may be missing direct route to head and neck cancer care Tens of thousands of Americans are diagnosed annually with head and neck cancers, but many adults are unaware of doctors who specialize in treating these conditions, according to a recent survey by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), the association representing America's ear, nose and throat (ENT) doctors. Acupuncture Eases Radiation-Induced Dry Mouth in Cancer Patients Twice weekly acupuncture treatments relieve debilitating symptoms of xerostomia - severe dry mouth - among patients treated with radiation for head and neck cancer, researchers from The University of Texas M. D. Anderson Cancer Center report in the current online issue of Head & Neck. Health choices predict cancer survival, U-M study finds Head and neck cancer patients who smoked, drank, didn't exercise or didn't eat enough fruit when they were diagnosed had worse survival outcomes than those with better health habits. Genetic Changes Outside Nuclear DNA Suspected to Trigger More Than Half of All Cancers A buildup of chemical bonds on certain cancer-promoting genes, a process known as hypermethylation, is widely known to render cells cancerous by disrupting biological brakes on runaway growth. Now, Johns Hopkins scientists say the reverse process - demethylation - which wipes off those chemical bonds may also trigger more than half of all cancers. Researchers identify genetic markers for aggressive head and neck cancer Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer. These findings could one day lead to a genetic test that could help select or predict successful treatment options for patients with this type of cancer. The results were published in the American Journal of Pathology. MRSA pre-screening effective in reducing otolaryngic surgical infection rates Pre-operative screening of patients for methicillin-resistant staphylococcus aureus (MRSA) may be an effective way to reduce infection rates following otolaryngic surgeries, according to new research published in the January 2009 issue of Otolaryngology - Head and Neck Surgery. New platinum-phosphate compounds kill ovarian cancer cells A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences. More Neck Cancer Current Events and Neck Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||